Related Experiment Videos

Severity of coronary artery disease in postmenopausal diabetic women

Katerina Saltiki1, Adrianna Cimponeriu, Kyriaki Lili

  • 1Endocrine Unit, Evgenidion Hospital and Department of Clinical Therapeutics, Alexandra University Hospital, Athens, Greece. saze@otenet.gr

Hormones (Athens, Greece)
|May 15, 2008
PubMed

Insights

Diabetic postmenopausal women have significantly more severe coronary artery disease (CAD) than non-diabetic women. Type 2 diabetes mellitus (T2DM) is an independent predictor of advanced CAD in this population.

Area of Science:

  • Cardiology
  • Endocrinology
  • Women's Health

Background:

  • Coronary artery disease (CAD) risk is elevated in postmenopausal women.
  • Diabetes is a known risk factor for cardiovascular disease.

Purpose of the Study:

  • To investigate the impact of diabetes on the severity of CAD in postmenopausal women.
  • To assess the relationship between type 2 diabetes mellitus (T2DM) and coronary atherosclerosis.

Main Methods:

  • Coronary angiography was performed on 180 postmenopausal women with suspected CAD.
  • CAD severity was quantified by the number of stenosed coronary arteries.
  • Clinical, biochemical, and hormonal data were collected, including T2DM status.

Main Results:

  • Diabetic women (n=44) exhibited a significantly higher prevalence of severe CAD (≥3 vessel disease) compared to non-diabetic women (p<0.001).
  • T2DM was an independent predictor of severe CAD, even after adjusting for age, BMI, hypertension, and hypercholesterolemia.
  • Diabetic women had lower sex hormone-binding globulin (SHBG) levels.

Conclusions:

  • Type 2 diabetes mellitus is associated with more severe coronary artery disease in postmenopausal women.
  • The findings suggest an independent role of T2DM in accelerating atherosclerosis in this demographic.
  • Further research into the mechanisms underlying this association is warranted.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...